News for 'India's Food and Drug Administration'

FDA Cracks Down On Hospital Pharmacies

FDA Cracks Down On Hospital Pharmacies

Rediff.com15 Jun 2026

'Hospitals sometimes compel patients to purchase medicines only from pharmacies owned by or attached to the hospital, refuse to provide prescriptions, withhold prescriptions, or send prescriptions directly to the hospital pharmacy without patient consent.'

Man Arrested In Thane Tobacco Products Seizure

Man Arrested In Thane Tobacco Products Seizure

Rediff.com18 Apr 2026

Police in Thane have arrested a 26-year-old man and seized banned tobacco products worth over Rs 5 lakh after a raid in Ulhasnagar.

Fake Paneer Manufacturing Unit Sealed In Aligarh

Fake Paneer Manufacturing Unit Sealed In Aligarh

Rediff.com30 Apr 2026

Police and FSDA officials in Aligarh, Uttar Pradesh, seized approximately 16 quintals of fake paneer allegedly made using detergent powder and other harmful chemicals. A manufacturing unit was sealed, and three individuals were booked in connection with the case as part of a state-wide crackdown on spurious milk products.

US Senator warns against poor-quality drugs from India

US Senator warns against poor-quality drugs from India

Rediff.com17 Oct 2025

United States Senator Jim Banks has urged the Food and Drug Administration (FDA) to step up inspections of overseas pharmaceutical manufacturing facilities, expressing concern over poor-quality drugs being imported from countries like India and China.

6 Ways To Get Fruits/Vegetables Pesticide-Free And Squeaky Clean

6 Ways To Get Fruits/Vegetables Pesticide-Free And Squeaky Clean

Rediff.com27 Apr 2026

From leafy greens to popular fruits, testing has shown varying levels of pesticide residues, raising concerns about routine exposure. Simple steps like washing, soaking, peeling and careful handling can help reduce potential risks.

India, US to continue efforts to finalise interim trade deal: USTR

India, US to continue efforts to finalise interim trade deal: USTR

Rediff.com2 Apr 2026

India and the United States are committed to finalising an interim trade agreement, despite recent challenges including the US imposing a blanket 10 per cent surcharge and India's decision to wait for a new global tariff architecture. The US Trade Representative's annual report highlights India's maintained high import tariffs and various non-tariff barriers across several sectors.

The Doctor Who Saved Thousands Of Babies

The Doctor Who Saved Thousands Of Babies

Rediff.com4 days ago

Thousands and thousands and thousands of adults owe their lives to the commitment and medical fervour of Dr Armida Fernandez, who a grateful nation honoured with the Padma Shri this year.

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Rediff.com4 Oct 2025

The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Kaysons Pharma following reports of children's deaths allegedly linked to contaminated cough syrup.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

Healthcare Funds: Caution Advised

Healthcare Funds: Caution Advised

Rediff.com12 Feb 2026

Most first-time investors may be better served by diversified options such as flexicap or multi-cap funds, which already hold pharma and healthcare stocks.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Tamil Nadu polls: AIADMK promises free fridge to voters

Tamil Nadu polls: AIADMK promises free fridge to voters

Rediff.com25 Mar 2026

AIADMK general secretary Edappadi K Palaniswami has announced a series of welfare measures, including free refrigerators for rice ration cardholders, if the party wins the 2026 Assembly election in Tamil Nadu.

Centre Moves To Bar Drugmakers Over Fake Information

Centre Moves To Bar Drugmakers Over Fake Information

Rediff.com3 Nov 2025

At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

US food regulator testing Maggi noodles after India recall

US food regulator testing Maggi noodles after India recall

Rediff.com11 Jun 2015

Nestle, the world's largest food company, is seeking to defend its reputation in India after it pulled Maggi noodles from stores.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Sena MLA booked for slapping canteen worker, threatens MIM leader

Sena MLA booked for slapping canteen worker, threatens MIM leader

Rediff.com12 Jul 2025

A non-cognisable offence is being filed against Shiv Sena MLA Sanjay Gaikwad in connection with the assault of a canteen worker at the MLA hostel. The incident sparked outrage after a video surfaced showing Gaikwad assaulting the worker over allegedly stale food.

'Medicines are just one part of the solution'

'Medicines are just one part of the solution'

Rediff.com21 May 2025

'We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a particular disease area globally.'

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com5 Jun 2025

'We recently launched Yesintek in the immunology space.'

Tirupati laddu row: Food safety regulator notice to ghee supplier

Tirupati laddu row: Food safety regulator notice to ghee supplier

Rediff.com23 Sep 2024

The controversy has sparked reactions across states. The famous Mankameshwar temple in Uttar Pradesh has now banned offerings of 'prasad' bought by devotees from outside and said they can offer homemade 'prasad' or fruits.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

States Seek Centre's Help To Deal With Trump's Tariffs

States Seek Centre's Help To Deal With Trump's Tariffs

Rediff.com2 Sep 2025

State governments have requested the Centre for export incentives, lifting of import duty in the case of cotton for the textile sector and GST exemptions.

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

Trump threatens steeper tariffs on India over Russian oil buy

Trump threatens steeper tariffs on India over Russian oil buy

Rediff.com4 Aug 2025

"India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump said in a social media post on Monday.

The side effects are real, but Sun Pharma stays on its feet

The side effects are real, but Sun Pharma stays on its feet

Rediff.com21 Apr 2025

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries, has clawed back nearly half of those losses. Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a diversified global presence have supported the recovery.

Phone Use on Toilet Linked To Piles

Phone Use on Toilet Linked To Piles

Rediff.com24 Feb 2025

The habit, coupled with a sedentary lifestyle and poor diet, is putting increased strain on the rectal area, leading to painful conditions that often require medical intervention.

Tirupati laddu row: Govt to wait for FSSAI report before action

Tirupati laddu row: Govt to wait for FSSAI report before action

Rediff.com23 Sep 2024

Amid the ongoing controversy over Tirupati laddu, Consumer Affairs Secretary Nidhi Khare on Monday said her department will consider additional measures to monitor ghee quality in the market only after receiving the Food Safety and Standards Authority of India (FSSAI) report.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

India could be 'efficacy test' for TB drug okayed by US

India could be 'efficacy test' for TB drug okayed by US

Rediff.com17 Mar 2013

There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Rediff.com23 May 2025

India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.

US: Indian couple sentenced for using unapproved cancer drugs

US: Indian couple sentenced for using unapproved cancer drugs

Rediff.com14 Jun 2014

A United States court has sentenced an Indian oncologist and his wife for using unapproved chemotherapy medications at their cancer institute for three years.

DCGI takes BIG step for rollout of foreign vaccines in India

DCGI takes BIG step for rollout of foreign vaccines in India

Rediff.com2 Jun 2021

"It has been decided that for approval of COVID-19 vaccines in India for restricted use in emergency situation which are already approved for restricted use by US Food Drug Administration, European Medicines Agency, UK Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency Japan or which are listed in WHO Emergency Use Listing and which are well established vaccines from the stand point that millions of individuals have already been vaccinated with the said vaccines, the requirement of conducting post approval bridging clinical trials and of testing every batch of vaccine by CDL, Kasauli can be exempted, if the vaccine batch/lot has been certified and released by National Control Laboratory of country of origin," it said.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).